Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis

Jin Lee, Sam Ryong Jee, Hyung Wook Kim, Dong Hoon Baek, Geun Am Song, Won Moon, Seun Ja Park, Hyun Jin Kim, Jong Hoon Lee, Jong Ha Park, Tae Oh Kim and for the Busan Ulsan Gyeongnam Intestinal Study Group Society (bigs)

PLOS ONE, 2019, vol. 14, issue 3, 1-11

Abstract: Background/Aims: It is well known that 5-aminosalicylic acid (5-ASA) is the standard first-line treatment for ulcerative colitis (UC). Medication adherence is an important factor in the treatment of UC. We aimed to identify predictors of low adherence to oral 5-ASA in Koreans with UC. Methods: Between July 2017 and January 2018, we performed a multicenter, cross-sectional study across 6 University Hospitals in Korea. Medication adherence was assessed using the modified Morisky Medication Adherence Scale (MMAS-8) questionnaire. Our study included 264 patients with UC. Patients were requested to complete the self-reported MMAS-8 questionnaire and a survey assessing sociodemographic data. Adherence was categorized as low (scores

Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214129 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 14129&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0214129

DOI: 10.1371/journal.pone.0214129

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().